Home › Funds › New York Life › NYLI Epoch Capital Growth Fund
Fund family: New York Life · Filed by NEW YORK LIFE INVESTMENTS FUNDS TRUST (CIK 1469192) · SEC series S000054257
Share classes and tickers: MECDX (C000170407), MECEX (C000170408), MECFX (C000170409), MECVX (C000170410)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,413 with, 71 against, 3 abstentions (not counted as with management); 29 items carried no recommendation. Shareholder proposals: 32 FOR, 54 AGAINST, 1 abstained, by the filing’s own vote-source field.
The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | New York Life | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 94.6% | 1,265 | 92.5% | 47,807 |
| Backed environmental and social shareholder proposals at US companies | n/a | 36 | 14.2% | 772 |
Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most New York Life funds on 11 items (1.7% of the 643 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most New York Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding a report on AI data usage oversight | Against | FOR — 6 of 6 New York Life funds | For | Not approved, 12.3% support |
| Microsoft Corporation | 2025-12-05 | Shareholder Report on Data Operations in Human Rights Hotspots | Against | FOR — 10 of 13 New York Life funds | For | Failed (calculated), 27.5% support |
| Microsoft Corporation | 2025-12-05 | Shareholder Report on Human Rights Due Diligence | Against | FOR — 10 of 13 New York Life funds | For | Failed (calculated), 26.3% support |
| Visa Inc. | 2026-01-27 | Shareholder Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. | Against | FOR — 4 of 5 New York Life funds | For | Not approved, 16.2% support |
| Alphabet Inc. | 2026-06-05 | Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stock | For | AGAINST — 4 of 6 New York Life funds | For | Approved, 90.4% support |
| Copart, Inc. | 2025-12-05 | To elect the twelve nominees for director named in this proxy statement to hold office until our 2026 annual meeting of stockholders or until their respective successors have been duly elected and qualified: Steven D. Cohan | For | AGAINST — 2 of 3 New York Life funds | For | Elected, 88.4% support |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Britt Meelby Jensen as New Director | For | ABSTAIN — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Cees de Jong (Vice Chair) as New Director | For | ABSTAIN — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Lars Rebien Sorensen (Chair) as New Director | For | ABSTAIN — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Mikael Dolsten as New Director | For | ABSTAIN — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Stephan Engels as New Director | For | ABSTAIN — 2 of 3 New York Life funds | — | — |
Download all 11 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 900 | 0 |
| Corporate Governance | 189 | 27 |
| Compensation | 105 | 2 |
| Audit-related | 103 | 0 |
| Capital Structure | 99 | 0 |
| Say-on-Pay | 71 | 0 |
| Other Social Issues | 23 | 20 |
| Environment or Climate | 12 | 12 |
| Shareholder Rights and Defenses | 9 | 4 |
| Human Rights or Human Capital/workforce | 6 | 6 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Lam Research Corporation | November 4, 2025 | $5M | 16 | 1 |
| Apple Inc. | February 24, 2026 | $4M | 12 | 1 |
| NVIDIA Corporation | June 24, 2026 | $4M | 16 | 4 |
| Meta Platforms, Inc. | May 27, 2026 | $3M | 22 | 9 |
| Regeneron Pharmaceuticals, Inc. | June 12, 2026 | $3M | 7 | 0 |
| AbbVie Inc. | May 8, 2026 | $3M | 8 | 1 |
| West Pharmaceutical Services, Inc. | May 4, 2026 | $3M | 14 | 1 |
| Mastercard Incorporated | June 16, 2026 | $2M | 15 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| November 4, 2025 | Lam Research Corporation | Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. Shareholder proposal | For | Against |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 8, 2026 | AbbVie Inc. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | For | Against |
| May 4, 2026 | West Pharmaceutical Services, Inc. | Shareholder proposal regarding an independent Board Chair policy. Shareholder proposal | For | Against |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal regarding shareholder right to act by written consent Shareholder proposal | For | Against |
| June 16, 2026 | Mastercard Incorporated | Consideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposal | Against | For |
| September 10, 2025 | NetApp, Inc. | To approve a stockholder proposal regarding support for Special Shareholder Meeting Improvement. Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
1,521 ballot items at 117 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, NYLI Epoch Capital Growth Fund (MECDX) voted at 117 shareholder meetings of 108 companies, on 1,521 ballot items in all. Where management made a recommendation, the fund followed it on 95.0% of the items and voted against it 71 times. Its most frequent area of disagreement was corporate governance (27 of its votes against management). It voted FOR 37.2% of the 86 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than New York Life's funds as a whole (94.6% against 92.5%). It voted differently from most New York Life funds on 11 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.